Study Details | To Evaluate the Efficacy and Safety of VIS649 in Participants with Immunoglobulin A (IgA) Nephropathy |
Protocol Number | VIS649 |
Phase | II |
Therapeutic Area | Nephrology |
Subject Types | With Medical Condition |
Indication | Immunoglobulin A (IgA) Nephropathy |
Principal Investigator | A/Prof Jimmy Teo Boon Wee |
Investigator Product / Device | VIS649 |
Sponsor | Visterra, Inc. |